Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer
Clinical trial NCT02626507 · UNKNOWN
Trial details
- NCT number
- NCT02626507
- Sponsor
- Hoffman Oncology
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2022-02-15
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.